STAT - Reporting from the frontiers of health and medicine

Health

Health

Biotech

Politics Big business lobbies bitterly divided over drug pricing reform
A STAT Investigation ‘Health equity tourists’: How white scholars are colonizing research on health disparities
Health STAT+ Conversation: How medicine’s biggest journals are confronting racism
First Opinion Paying participants isn’t the way to improve clinical trial recruitment
Biotech Graduate students launch an entrepreneurship program to bring new faces to biotech

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Inflation and rebates caused wholesale prices on medicines to drop in second quarter
WHO adds Regeneron drug to recommended Covid-19 treatments, but criticizes its pricing
Pharmalittle: Sanofi ends work on mRNA Covid-19 vaccine; Biogen seeks fast FDA approval of another Alzheimer’s drug

Health

A STAT Investigation

Health

Special Report

Health Tech

Health

A STAT Investigation ‘Health equity tourists’: How white scholars are colonizing research on health disparities
Health Side effect rates from a third Covid-19 vaccine dose similar to those after second shot, early data indicate
Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
First Opinion How a ‘fatally, tragically flawed’ paradigm has derailed the science of obesity
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Health How the risk of side effects could change with Covid-19 vaccine boosters
Matt's Take The Biden administration wants scientific advisers. It just doesn’t like what they have to say
A STAT Investigation Epic’s sepsis algorithm is going off the rails in the real world. The use of these variables may explain why